Cargando…

Modulation of cardiac ionic homeostasis by 3-iodothyronamine

3-iodothyronamine (T(1)AM) is a novel endogenous relative of thyroid hormone, able to interact with trace amine-associated receptors, a class of plasma membrane G protein-coupled receptors, and to produce a negative inotropic and chronotropic effect. In the isolated rat heart 20–25 μM T(1)AM decreas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghelardoni, Sandra, Suffredini, Silvia, Frascarelli, Sabina, Brogioni, Simona, Chiellini, Grazia, Ronca-Testoni, Simonetta, Grandy, David K, Scanlan, Thomas S, Cerbai, Elisabetta, Zucchi, Riccardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Ltd 2009
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516467/ https://www.ncbi.nlm.nih.gov/pubmed/19298522 http://dx.doi.org/10.1111/j.1582-4934.2009.00728.x

Ejemplares similares

Modulation of Gene Expression by 3-Iodothyronamine: Genetic Evidence for a Lipolytic Pattern
por: Mariotti, Veronica, et al.
Publicado: (2014)

Update on 3-iodothyronamine and its neurological and metabolic actions
por: Zucchi, Riccardo, et al.
Publicado: (2014)

Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression
por: Assadi-Porter, Fariba M., et al.
Publicado: (2018)

3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
por: Rutigliano, Grazia, et al.
Publicado: (2020)

Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3‐iodothyronamine
por: Selen Alpergin, Ebru S., et al.
Publicado: (2017)

Effect of Combined Levothyroxine (L-T(4)) and 3-Iodothyronamine (T(1)AM) Supplementation on Memory and Adult Hippocampal Neurogenesis in a Mouse Model of Hypothyroidism
por: Rutigliano, Grazia, et al.
Publicado: (2023)

New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection
por: Bellusci, Lorenza, et al.
Publicado: (2017)

Endogenous 3-Iodothyronamine (T1AM) and Synthetic Thyronamine-Like Analog SG-2 Act as Novel Pleiotropic Neuroprotective Agents through the Modulation of SIRT6
por: Bellusci, Lorenza, et al.
Publicado: (2020)

3-Iodothyronamine Affects Thermogenic Substrates’ Mobilization in Brown Adipocytes
por: Gencarelli, Manuela, et al.
Publicado: (2020)

3,5-Diiodo-l-Thyronine Increases Glucose Consumption in Cardiomyoblasts Without Affecting the Contractile Performance in Rat Heart
por: Sacripanti, Ginevra, et al.
Publicado: (2018)

Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway
por: Rogowski, Michael, et al.
Publicado: (2019)

Thyroxine metabolite-derived 3-iodothyronamine (T1AM) and synthetic analogs as efficient suppressors of transthyretin amyloidosis
por: Kim, Bokyung, et al.
Publicado: (2023)

Exogenous 3-Iodothyronamine (T(1)AM) Can Affect Phosphorylation of Proteins Involved on Signal Transduction Pathways in In Vitro Models of Brain Cell Lines, but These Effects Are Not Strengthened by Its Catabolite, 3-Iodothyroacetic Acid (TA(1))
por: Bandini, Lavinia, et al.
Publicado: (2022)

Uptake of 3‐iodothyronamine hormone analogs inhibits the growth and viability of cancer cells
por: Rogowski, Michael, et al.
Publicado: (2017)

Inverse Agonistic Action of 3-Iodothyronamine at the Human Trace Amine-Associated Receptor 5
por: Dinter, Juliane, et al.
Publicado: (2015)

Commentary: 3-Iodothyronamine Reduces Insulin Secretion In Vitro via a Mitochondrial Mechanism
por: Laurino, Annunziatina, et al.
Publicado: (2018)

Central Effects of 3-Iodothyronamine Reveal a Novel Role for Mitochondrial Monoamine Oxidases
por: Laurino, Annunziatina, et al.
Publicado: (2018)

3-Iodothyronamine Activates a Set of Membrane Proteins in Murine Hypothalamic Cell Lines
por: Bräunig, Julia, et al.
Publicado: (2018)

3-Iodothyronamine, a Novel Endogenous Modulator of Transient Receptor Potential Melastatin 8?
por: Khajavi, Noushafarin, et al.
Publicado: (2017)

Behavioral hypothermia of a domesticated lizard under treatment of the hypometabolic agent 3-iodothyronamine
por: Ha, Kyoungbong, et al.
Publicado: (2016)

Redox Properties of 3-Iodothyronamine (T1AM) and 3-Iodothyroacetic Acid (TA1)
por: Gencarelli, Manuela, et al.
Publicado: (2022)

T1AM/TAAR1 System Reduces Inflammatory Response and β-Amyloid Toxicity in Human Microglial HMC3 Cell Line
por: Polini, Beatrice, et al.
Publicado: (2023)

Striatal Tyrosine Hydroxylase Is Stimulated via TAAR1 by 3-Iodothyronamine, But Not by Tyramine or β-Phenylethylamine
por: Zhang, Xiaoqun, et al.
Publicado: (2018)

Altered Ca(2+) and Na(+) Homeostasis in Human Hypertrophic Cardiomyopathy: Implications for Arrhythmogenesis
por: Coppini, Raffaele, et al.
Publicado: (2018)

Ionic homeostasis in brain conditioning
por: Cuomo, Ornella, et al.
Publicado: (2015)

The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor
por: Bräunig, Julia, et al.
Publicado: (2018)

3-iodothyronamine inhibits apoptosis induced by myocardial ischemia reperfusion via the Akt/FoxO1 signaling pathway
por: Zhou, Haiyan, et al.
Publicado: (2022)

Assay of Endogenous 3,5-diiodo-L-thyronine (3,5-T(2)) and 3,3′-diiodo-L-thyronine (3,3′-T(2)) in Human Serum: A Feasibility Study
por: Lorenzini, Leonardo, et al.
Publicado: (2019)

Vitamin D measurement and effect on outcome in a cohort of patients with heart failure
por: Saponaro, Federica, et al.
Publicado: (2018)

TRPM8 Activation via 3-Iodothyronamine Blunts VEGF-Induced Transactivation of TRPV1 in Human Uveal Melanoma Cells
por: Walcher, Lia, et al.
Publicado: (2018)

Comparative Transcriptome Analysis Reveals the Potential Cardiovascular Protective Targets of the Thyroid Hormone Metabolite 3-Iodothyronamine (3-T1AM)
por: Haiyan, Zhou, et al.
Publicado: (2020)

Substantial impact of 3-iodothyronamine (T1AM) on the regulations of fluorescent thermoprobe-measured cellular temperature and natriuretic peptide expression in cardiomyocytes
por: Takahashi, Hirotake, et al.
Publicado: (2022)

The logic of ionic homeostasis: Cations are for voltage, but not for volume
por: Dmitriev, Andrey V., et al.
Publicado: (2019)

NMR-based metabolomics and breath studies show lipid and protein catabolism during low dose chronic T(1)AM treatment
por: Haviland, J. A., et al.
Publicado: (2013)

Vascular Progenitor Cells: From Cancer to Tissue Repair
por: Barachini, Serena, et al.
Publicado: (2023)

Molecular Variants in Human Trace Amine-Associated Receptors and Their Implications in Mental and Metabolic Disorders
por: Rutigliano, Grazia, et al.
Publicado: (2019)

Endoplasmic Reticulum Membrane Reorganization Is Regulated by Ionic Homeostasis
por: Varadarajan, Shankar, et al.
Publicado: (2013)

Proanthocyanidins Maintain Cardiac Ionic Homeostasis in Aldosterone-Induced Hypertension and Heart Failure
por: de las Heras, Natalia, et al.
Publicado: (2021)

New Multitarget Approaches in the War Against Glioblastoma: A Mini-Perspective
por: Sestito, Simona, et al.
Publicado: (2018)

Selective Thyroid Hormone Receptor-Beta (TRβ) Agonists: New Perspectives for the Treatment of Metabolic and Neurodegenerative Disorders
por: Saponaro, Federica, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mtkisnl343jbtu7vr75nt0uq5j